The drug liking and craving questionnaire (DLCQ) to evaluate addiction risk for ketamine and esketamine
Ketamine and esketamine (SPRAVATO) are rapid acting antidepressants that have gained evidence and popularity in recent years in treating depression, and are under investigation for other psychiatric indications. Ketamine is a potential drug of abuse and the addiction potential of these medications h...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Psychiatry Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772598721000180 |